Related Experiment Video
Updated: Sep 28, 2025

A Semi-High-Throughput Adaptation of the NADH-Coupled ATPase Assay for Screening Small Molecule Inhibitors
Published on: August 17, 2019
Discovery of small-molecule inhibitors of RUVBL1/2 ATPase
Gang Zhang1, Feng Wang1, Shan Li1
1Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, United States.
Abstract:
RUVBL1 and RUVBL2 are highly conserved AAA ATPases (ATPases Associated with various cellular Activities) and highly relevant to the progression of cancer, which makes them attractive targets for novel therapeutic anticancer drugs. In this work, docking-based virtual screening was performed to identify compounds with activity against the RUVBL1/2 complex. Seven compounds showed inhibitory activity against the complex in both enzymatic and cellular assays. A series of pyrazolo[1,5-a]pyrimidine-3-carboxamide analogs were synthesized based on the scaffold of compound 15 with inhibitory activity and good potential for structural manipulation. Analysis of the structure-activity relationship identified the benzyl group on R2 and aromatic ring-substituted piperazinyl on R4 as essential for inhibitory activity against the RUVBL1/2 complex. Of these, compound 18, which has IC50 values of 6.0 ± 0.6 μM and 7.7 ± 0.9 μM against RUVBL1/2 complex and RUVBL1 respectively, showed the most potent inhibition in cell lines A549, H1795, HCT116, and MDA-MB-231 with IC50 values of 15 ± 1.2 μM, 15 ± 1.8 μM, 11 ± 1.0 μM, and 8.9 ± 0.9 μM respectively. A docking study of the compound was performed to predict the binding mode of pyrazolo[1,5-a]pyrimidine-3-carboxamides. Furthermore, mass spectrometry-based proteomic analysis was employed to explore cellular proteins dysregulated by treatment with compounds 16, 18, and 19. Together, the data from these analyses suggest that that compound 18 could serve as a starting point for structural modifications in order to improve potency, selectivity, and pharmacokinetic parameters of potential therapeutic molecules.
Insights
Researchers identified novel pyrazolo[1,5-a]pyrimidine-3-carboxamide compounds targeting RUVBL1/2 ATPases, crucial in cancer progression. Compound 18 demonstrated significant inhibitory activity, offering a promising lead for new anticancer drug development.
Area of Science:
- Medicinal Chemistry
- Molecular Biology
- Oncology
Background:
- RUVBL1 and RUVBL2 are highly conserved AAA ATPases implicated in cancer progression.
- These ATPases are attractive targets for developing novel anticancer therapeutics.
Purpose of the Study:
- To identify compounds with inhibitory activity against the RUVBL1/2 complex using docking-based virtual screening.
- To synthesize and evaluate pyrazolo[1,5-a]pyrimidine-3-carboxamide analogs as potential anticancer agents.
Main Methods:
- Docking-based virtual screening to identify initial hits.
- Synthesis of pyrazolo[1,5-a]pyrimidine-3-carboxamide analogs.
- Enzymatic and cellular assays to determine inhibitory activity.
- Structure-activity relationship analysis.
- Mass spectrometry-based proteomic analysis to explore cellular effects.
Main Results:
- Seven compounds exhibited inhibitory activity against the RUVBL1/2 complex.
- Compound 18 showed potent inhibition with IC50 values of 6.0 ± 0.6 μM (RUVBL1/2 complex) and 7.7 ± 0.9 μM (RUVBL1).
- Compound 18 demonstrated significant IC50 values in various cancer cell lines (A549, H1795, HCT116, MDA-MB-231).
- Structure-activity relationship studies identified key structural features for inhibitory activity.
Conclusions:
- Compound 18 is a potent inhibitor of the RUVBL1/2 complex and exhibits anticancer activity in multiple cell lines.
- The pyrazolo[1,5-a]pyrimidine-3-carboxamide scaffold serves as a promising starting point for developing improved anticancer therapeutics.
- Further structural modifications of compound 18 are warranted to optimize potency, selectivity, and pharmacokinetic properties.
More Related Videos
11:34High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
Published on: May 5, 2014
10:24NMR-Based Activity Assays for Determining Compound Inhibition, IC50 Values, Artifactual Activity, and Whole-Cell Activity of Nucleoside Ribohydrolases
Published on: June 30, 2019
Related Concept Videos
ATP Synthase: Mechanism
ATP Driven Pumps III: V-type Pumps
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
ATP Driven Pumps I: An Overview
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Pinching-off of Coated Vesicles
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...